-
Communities
-
Explore Vanderbilt communities
By latest
Featured community
Creative Data Solutions (CDS) is a Vanderbilt Shared Resource and has extensive experience in providing effective and robust solutions to challenges pertaining to research data using modern informatics and bioinformatics approaches.
-
- Resources
-
People
-
Publications
-
Explore publications
-
Type 2 Diabetes Drug Study
TBD
- Category
- Page
- Record History
- Added on September 22, 2017 at 1:01 PM by Kimber, Jessica
Modified on September 25, 2017 at 10:21 AM by Kimber, Jessica - Shared with (contributions)
- DRTC: Clinical Trials
Type 2 Diabetes Drug Study
The purpose of this study is to achieve glycemic control with a
drug intervention in patients with Type 2 Diabetes.
To qualify to participate:
- 18 years to 80 years of age
- A known history of Type 2 Diabetes receiving diet alone or oral
antidiabetic drugs (including insulin secretagogues, pioglitazone,
DPP4 inhibitors, or metformin as monotherapy or in combination
therapy, or low-dose insulin at <0.5 unit/kg/day)
- Discharged after hospital admission from general
admission from general medicine and surgery services
(non-Intensive Care Unit setting)
- BMI range: > 25 Kg/m^2 and < 45 Kg/m^2
How to Participate
To participate, contact Jonathan Williams at (615) 875-9200 or e-mail at jonathan.m.williams@vanderbilt.edu.
